
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AME_L | 214 | 49.1% | 3.54 | 2,482 | 61.4% |
| ME_L | 139 | 31.9% | 3.15 | 1,230 | 30.4% |
| PVLP_L | 20 | 4.6% | 3.50 | 227 | 5.6% |
| LA_L | 63 | 14.4% | 0.68 | 101 | 2.5% |
| upstream partner | # | NT | conns HBeyelet | % In | CV |
|---|---|---|---|---|---|
| HBeyelet (L) | 4 | Unk | 60.8 | 71.5% | 0.3 |
| aMe4 (L) | 8 | ACh | 5.5 | 6.5% | 0.7 |
| OA-AL2i3 (L) | 2 | OA | 5 | 5.9% | 0.4 |
| aMe5 (L) | 6 | ACh | 3.8 | 4.4% | 0.4 |
| aMe6c (L) | 1 | Unk | 1.8 | 2.1% | 0.0 |
| MeMe_e11 (R) | 2 | ACh | 1.2 | 1.5% | 0.6 |
| aMe10 (R) | 1 | ACh | 1 | 1.2% | 0.0 |
| Lat (L) | 2 | Unk | 1 | 1.2% | 0.5 |
| aMe1 (L) | 2 | GABA | 1 | 1.2% | 0.0 |
| aMe3 (L) | 1 | Unk | 0.8 | 0.9% | 0.0 |
| cM08b (L) | 2 | Glu | 0.5 | 0.6% | 0.0 |
| l-LNv (R) | 2 | 5-HT | 0.5 | 0.6% | 0.0 |
| C2 (L) | 1 | Unk | 0.2 | 0.3% | 0.0 |
| aMe6a (L) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| MTe37 (L) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| OA-AL2b2 (R) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| OA-AL2b2 (L) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| aMe12 (L) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| PDt1 (L) | 1 | DA | 0.2 | 0.3% | 0.0 |
| aMe6b (L) | 1 | ACh | 0.2 | 0.3% | 0.0 |
| C3 (L) | 1 | GABA | 0.2 | 0.3% | 0.0 |
| downstream partner | # | NT | conns HBeyelet | % Out | CV |
|---|---|---|---|---|---|
| aMe6c (L) | 2 | Unk | 138 | 26.3% | 0.3 |
| aMe6b (L) | 1 | ACh | 66.2 | 12.6% | 0.0 |
| aMe6a (L) | 1 | ACh | 61 | 11.6% | 0.0 |
| HBeyelet (L) | 4 | Unk | 60.8 | 11.6% | 0.2 |
| aMe3 (L) | 1 | Unk | 43.5 | 8.3% | 0.0 |
| aMe5 (L) | 15 | ACh | 33.5 | 6.4% | 0.9 |
| cM09 (L) | 2 | Unk | 19.5 | 3.7% | 0.1 |
| aMe1 (L) | 2 | GABA | 16.5 | 3.1% | 1.0 |
| uncertain (L) | 1 | ACh | 15.2 | 2.9% | 0.0 |
| l-LNv (L) | 3 | 5-HT | 9 | 1.7% | 0.5 |
| aMe4 (L) | 8 | ACh | 7.2 | 1.4% | 0.5 |
| MTe40 (L) | 1 | ACh | 6.8 | 1.3% | 0.0 |
| OA-AL2i3 (L) | 2 | OA | 5.2 | 1.0% | 0.2 |
| s-LNv_b (L) | 4 | ACh | 5 | 1.0% | 0.6 |
| Sm34 (L) | 3 | Glu | 3 | 0.6% | 0.5 |
| aMe12 (L) | 1 | ACh | 2.5 | 0.5% | 0.0 |
| MeMe_e11 (R) | 2 | ACh | 2.2 | 0.4% | 0.1 |
| cM04 (L) | 3 | Glu | 2 | 0.4% | 0.5 |
| Lat (L) | 3 | Unk | 2 | 0.4% | 0.2 |
| cM11 (L) | 1 | ACh | 1.8 | 0.3% | 0.0 |
| Li09 (L) | 2 | GABA | 1.8 | 0.3% | 0.4 |
| aMe10 (L) | 1 | ACh | 1.5 | 0.3% | 0.0 |
| MLt4 (L) | 6 | ACh | 1.5 | 0.3% | 0.0 |
| LTe71 (L) | 1 | Glu | 1.2 | 0.2% | 0.0 |
| C2 (L) | 1 | Unk | 1 | 0.2% | 0.0 |
| 5-HT-IR Tan (L) | 1 | Unk | 1 | 0.2% | 0.0 |
| Tm5c (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| Dm3q (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| aMe17a2 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| Li06 (L) | 1 | ACh | 0.8 | 0.1% | 0.0 |
| aMe17c (L) | 1 | Unk | 0.8 | 0.1% | 0.0 |
| L1 (L) | 1 | Glu | 0.8 | 0.1% | 0.0 |
| MTe01b (L) | 3 | ACh | 0.8 | 0.1% | 0.0 |
| cL10 (L) | 1 | Glu | 0.8 | 0.1% | 0.0 |
| Sm02 (L) | 2 | ACh | 0.8 | 0.1% | 0.3 |
| aMe22 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| DNp27 (L) | 1 | 5-HT | 0.5 | 0.1% | 0.0 |
| MTe51 (L) | 2 | ACh | 0.5 | 0.1% | 0.0 |
| Sm01 (L) | 2 | ACh | 0.5 | 0.1% | 0.0 |
| DN1a (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| Mi15 (L) | 1 | ACh | 0.5 | 0.1% | 0.0 |
| LMa3 (L) | 1 | Glu | 0.5 | 0.1% | 0.0 |
| L2 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| MTe24 (L) | 1 | Unk | 0.2 | 0.0% | 0.0 |
| MLt1 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| C3 (L) | 1 | GABA | 0.2 | 0.0% | 0.0 |
| Sm25 (L) | 1 | GABA | 0.2 | 0.0% | 0.0 |
| cM08b (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| MTe54 (L) | 1 | Unk | 0.2 | 0.0% | 0.0 |
| LMTe01 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| Pm07 (L) | 1 | GABA | 0.2 | 0.0% | 0.0 |
| MeMe_e11 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| cM07 (L) | 1 | Glu | 0.2 | 0.0% | 0.0 |
| Lawf1 (L) | 1 | Unk | 0.2 | 0.0% | 0.0 |
| OA-AL2b2 (R) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| Tm20 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| Sm27 (L) | 1 | GABA | 0.2 | 0.0% | 0.0 |
| cM13 (R) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| MTe02 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 |
| Sm40 (L) | 1 | GABA | 0.2 | 0.0% | 0.0 |